Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Akari Therapeutics (AKTX)

Akari Therapeutics (AKTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Akari Therapeutics 75/76 WIMPOLE STREET LONDON X0 W1G 9RT GBR

P: 646-350-0702

Description:

Akari Therapeutics PLC is a biopharmaceutical company. It focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. The Company's lead drug consist of Coversin is a recombinant small protein, which acts on complement component-C5, preventing release of C5a and formation of C5b-9. Akari Therapeutics PLC, formerly known as Celsus Therapeutics Plc, is based in London, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 27,488
Shares Outstanding, K 15,857
Annual Sales, $ 0 K
Annual Net Income, $ -16,470 K
60-Month Beta -2.90
% of Insider Shareholders 61.80%
% of Institutional Shareholders 15.70%
Float, K 6,057
% Float 38.20%

Growth:

1-Year Return -3.33%
3-Year Return -80.30%
5-Year Return -97.13%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 90.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/21/19
Earnings Per Share ttm -0.45
EPS Growth vs. Prev Qtr -62.50%
EPS Growth vs. Prev Year 7.14%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 09/17/15

AKTX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.67
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -761.64
Return-on-Assets (Before Tax) -203.75
Profit Margin % N/A
Net Margin % N/A
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar